Dexmedetomidine — the highly selective alpha-2 adrenergic receptor agonist providing sedation with preserved respiratory drive, reduced delirium incidence, and enhanced patient arousability for communication and cooperation during mechanical ventilation — represents the fastest-growing sedative agent in ICU sedation, with the Sedation In ICU Setting Market reflecting dexmedetomidine...